Heterotropic Cooperativity within and between Protomers of an Oligomeric M2 Muscarinic Receptor

被引:8
|
作者
Shivnaraine, Rabindra V. [1 ]
Huang, Xi-Ping [2 ,3 ]
Seidenberg, Margaret [2 ,3 ]
Ellis, John [2 ,3 ]
Wells, James W. [1 ]
机构
[1] Univ Toronto, Leslie Dan Fac Pharm, Dept Pharmaceut Sci, Toronto, ON M5S 3M2, Canada
[2] Penn State Univ, Coll Med, Hershey Med Ctr, Dept Psychiat, Hershey, PA 17033 USA
[3] Penn State Univ, Coll Med, Hershey Med Ctr, Dept Pharmacol, Hershey, PA 17033 USA
基金
美国国家卫生研究院; 加拿大健康研究院;
关键词
PROTEIN-COUPLED RECEPTORS; COMMON ALLOSTERIC SITE; GTP-BINDING PROTEINS; ACETYLCHOLINE-RECEPTORS; CHOLINERGIC-RECEPTOR; SF9; CELLS; ANTAGONIST BINDING; DOPAMINE-RECEPTORS; AMILORIDE ANALOGS; PORCINE ATRIA;
D O I
10.1021/bi3000287
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
At least four allosteric sites have been found to mediate the dose-dependent effects of gallamine on the binding of [H-3]quinuclidinylbenzilate (QNB) and N-[H-3]methylscopolamine (NMS) to M-2 muscarinic receptors in membranes and solubilized preparations from porcine atria, CHO cells, and Sf9 cells. The rate of dissociation of [H-3]QNB was affected in a bell-shaped manner with at least one Hill coefficient (n(H)) greater than 1, indicating that at least three allosteric sites are involved. The level of binding of [H-3]QNB was decreased in a biphasic manner, revealing at least two allosteric sites; binding of [H-3]NMS was affected in a triphasic, serpentine manner, revealing at least three sites, and values of n(H) >1 pointed to at least four sites. Several lines of evidence indicate that all effects of gallamine were allosteric in nature and could be observed at equilibrium. The rates of equilibration and dissociation suggest that the receptor was predominately oligomeric, and the heterogeneity revealed by gallamine can be attributed to differences in its affinity for the constituent protomers of a tetramer. Those differences appear to arise from inter- and intramolecular cooperativity between gallamine and the radioligand.
引用
收藏
页码:4518 / 4540
页数:23
相关论文
共 50 条
  • [1] Oligomeric stability of the m2 muscarinic receptor
    Park, P
    Van Tol, HHM
    Wells, JW
    LIFE SCIENCES, 2001, 68 (22-23) : 2622 - 2622
  • [2] Oligomeric potential of the M2 muscarinic cholinergic receptor
    Park, PSH
    Wells, JW
    JOURNAL OF NEUROCHEMISTRY, 2004, 90 (03) : 537 - 548
  • [3] Cholesterol as a determinant of cooperativity in the M2 muscarinic cholinergic receptor
    Colozo, Alejandro T.
    Park, Paul S. -H.
    Sum, Chi Shing
    Pisterzi, Luca F.
    Wells, James W.
    BIOCHEMICAL PHARMACOLOGY, 2007, 74 (02) : 236 - 255
  • [4] Cooperativity in the Binding of Agonists to Reconstituted Tetramers of the M2 Muscarinic Receptor
    Redka, Dar'ya S.
    Heerklotz, Heiko
    Wells, James W.
    BIOPHYSICAL JOURNAL, 2011, 100 (03) : 420 - 420
  • [5] Efficacy As An Intrinsic Property of the M2 Muscarinic Receptor in Its Oligomeric State
    Redka, Dar'ya S.
    Heerklotz, Heiko
    Wells, James W.
    BIOPHYSICAL JOURNAL, 2010, 98 (03) : 34A - 34A
  • [6] Atypical muscarinic allosteric modulation:: Cooperativity between modulators and their atypical binding topology in muscarinic M2 and M2/M5 chimeric receptors
    Tränkle, C
    Dittmann, A
    Schulz, U
    Weyand, O
    Buller, S
    Jöhren, K
    Heller, E
    Birdsall, NJM
    Holzgrabe, U
    Ellis, J
    Höltje, HD
    Mohr, K
    MOLECULAR PHARMACOLOGY, 2005, 68 (06) : 1597 - 1610
  • [7] Recovery of oligomers and cooperativity when monomers of the M2 muscarinic cholinergic receptor are reconstituted into phospholipid vesicles
    Ma, Amy W. -S.
    Redka, Dar'ya S.
    Pisterzi, Luca F.
    Angers, Stephane
    Wells, James W.
    BIOCHEMISTRY, 2007, 46 (26) : 7907 - 7927
  • [8] Potent M2 muscarinic receptor antagonists
    Barrett, D
    Barlocco, D
    DRUG DISCOVERY TODAY, 2001, 6 (05) : 268 - 268
  • [9] A novel function of the M2 muscarinic receptor
    Wess, Jurgen
    Liu, Liu
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2024, 45 (08) : 663 - 665
  • [10] Protean agonism at the muscarinic M2 receptor
    Demin, A.
    Matera, C.
    Messerer, R.
    Dallanoce, C.
    Holzgrabe, U.
    Mohr, K.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2015, 388 : S4 - S4